Gene Review:
S100a11 - S100 calcium binding protein A11...
Mus musculus
Synonyms:
Calgizzarin, EMAP, EMAPI, Emap1, Endothelial monocyte-activating polypeptide, ...
- Effects of 2,4-dinitrophenol and other metabolic inhibitors on the thermograms of Ehrlich ascites carcinoma cells registered with a microcalorimeter. Ito, E., Sakihama, H., Toyama, K., Matsui, K. Cancer Res. (1984)
- Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus. Gnant, M.F., Berger, A.C., Huang, J., Puhlmann, M., Wu, P.C., Merino, M.J., Bartlett, D.L., Alexander, H.R., Libutti, S.K. Cancer Res. (1999)
- Regulation of EMAP II by hypoxia. Matschurat, S., Knies, U.E., Person, V., Fink, L., Stoelcker, B., Ebenebe, C., Behrensdorf, H.A., Schaper, J., Clauss, M. Am. J. Pathol. (2003)
- Control of stromal keratitis by inhibition of neovascularization. Zheng, M., Schwarz, M.A., Lee, S., Kumaraguru, U., Rouse, B.T. Am. J. Pathol. (2001)
- Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. Schwarz, M.A., Kandel, J., Brett, J., Li, J., Hayward, J., Schwarz, R.E., Chappey, O., Wautier, J.L., Chabot, J., Lo Gerfo, P., Stern, D. J. Exp. Med. (1999)
- Binding properties of immunoglobulin combining sites specific for terminal or nonterminal antigenic determinants in dextran. Cisar, J., Kabat, E.A., Dorner, M.M., Liao, J. J. Exp. Med. (1975)
- Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Knies, U.E., Behrensdorf, H.A., Mitchell, C.A., Deutsch, U., Risau, W., Drexler, H.C., Clauss, M. Proc. Natl. Acad. Sci. U.S.A. (1998)
- Calyculin A modulates the kinetic constants for the Na+-coupled taurine transport in Ehrlich ascites tumour cells. Mollerup, J., Lambert, I.H. Biochim. Biophys. Acta (1998)
- Apoptosis induced by a corneal-endothelium-derived cytokine. Liu, S.H., Gottsch, J.D. Invest. Ophthalmol. Vis. Sci. (1999)
- Developmental stage- and germ cell-regulated expression of a calcium-binding protein mRNA in mouse Sertoli cells. Kraszucka, K., Burfeind, P., Nayernia, K., Köhler, M., Schmid, M., Yaylaoglu, M., Engel, W. Mol. Reprod. Dev. (1999)
- Calgizarrin like gene (Cal) deficient mice undergo normal spermatogenesis. Mannan, A.U., Nica, G., Nayernia, K., Mueller, C., Engel, W. Mol. Reprod. Dev. (2003)
- Epithelial-mesenchymal interactions are linked to neovascularization. Schwarz, M.A., Wan, Z., Liu, J., Lee, M.K. Am. J. Respir. Cell Mol. Biol. (2004)
- Binding kinetics and physical properties of androgen receptor in androgen-dependent Shionogi mammary carcinoma 115. Nohno, T. J. Biochem. (1981)
- Adipocyte lipid-binding protein complexed with arachidonic acid. Titration calorimetry and X-ray crystallographic studies. LaLonde, J.M., Levenson, M.A., Roe, J.J., Bernlohr, D.A., Banaszak, L.J. J. Biol. Chem. (1994)
- An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker. Hamann, P.R., Hinman, L.M., Beyer, C.F., Lindh, D., Upeslacis, J., Flowers, D.A., Bernstein, I. Bioconjug. Chem. (2002)
- Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Chaurand, P., DaGue, B.B., Pearsall, R.S., Threadgill, D.W., Caprioli, R.M. Proteomics (2001)
- Upregulation of macrophage migration inhibitory factor and calgizzarin by androgen in TM4 mouse Sertoli cells. Kasumi, H., Komori, S., Sakata, K., Yamamoto, N., Yamasaki, T., Kanemura, Y., Koyama, K. Asian J. Androl. (2006)
- Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Hamann, P.R., Hinman, L.M., Hollander, I., Beyer, C.F., Lindh, D., Holcomb, R., Hallett, W., Tsou, H.R., Upeslacis, J., Shochat, D., Mountain, A., Flowers, D.A., Bernstein, I. Bioconjug. Chem. (2002)
- Endothelial monocyte activating polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis. Schwarz, M.A., Zhang, F., Gebb, S., Starnes, V., Warburton, D. Mech. Dev. (2000)
- EMAP II: a modulator of neovascularization in the developing lung. Schwarz, M., Lee, M., Zhang, F., Zhao, J., Jin, Y., Smith, S., Bhuva, J., Stern, D., Warburton, D., Starnes, V. Am. J. Physiol. (1999)
- Animal models of anxiety. Ohl, F. Handbook of experimental pharmacology. (2005)









